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Abstract
Background: Destabilase-Lysozyme (mlDL) is a multifunctional i-type enzyme that has been found in the secretions
from the salivary glands of medicinal leeches. mlDL has been shown to exhibit isopeptidase, muramidase and
antibacterial activity. This enzyme attracts interest because it expresses thrombolytic activity through isopeptidolysis
of the ε-(γ-Glu)-Lys bonds that cross-link polypeptide chains in stabilised fibrin. To date, three isoforms of mlDL
have been identified.
The enzymatic properties of pure mlDL isoforms have not yet been described because only destabilase complexes
containing other proteins could be isolated from the salivary gland secretion and because low product yield from
the generation of recombinant proteins has made comprehensive testing difficult.
Results: In the present study, we optimised the procedures related to the expression, isolation and purification of
active mlDL isoforms (mlDL-Ds1, mlDL-Ds2, mlDL-Ds3) using an Escherichia coli expression system, and we detected
and compared their muramidase, lytic, isopeptidase and antimicrobial activities. After optimisation, the product
yield was 30 mg per litre of culture. The data obtained in our study led to the suggestion that the recombinant
mlDL isoforms isolated from inclusion bodies form stable oligomeric complexes. Analyses of the tested activities
revealed that all isoforms exhibited almost identical patterns of pH and ionic strength effects on the activities. We
determined that mlDL-Ds1, 2, 3 possessed non-enzymatic antibacterial activity independent of their muramidase
activity. For the first time, we demonstrated the fibrinolytic activity of the recombinant mlDL and showed that only
intact proteins possessed this activity, suggesting their enzymatic nature.
Conclusions: The recombinant Destabilase-Lysozyme isoforms obtained in our study may be considered potential
thrombolytic agents that act through a mechanism different from that of common thrombolytics.
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Background
The use of blood-sucking leeches for medical purposes
in humans has been known since ancient times [1, 2].
The leeches were mainly used for bloodletting because
evolutionary adaptations of their feeding apparatus pro-
mote the inhibition of haemostasis and blood coagulation
[3–5]. The composition of leech salivary gland secretions
plays a major role in this inhibition [3, 6–8]. Moreover, in
1948, the salivary gland secretions of leeches were shown
to have thrombolytic activity [9]. Decades later, in 1984,
Baskova and Nikonov revealed that destabilised fibrin
depolymerisation occurred after the application of leech
salivary gland secretions on stabilised fibrin plates only
[6]. Moreover, the process of fibrinolysis held better on a
more stabilized fibrin by factor XIIIa. The authors pro-
posed that leech salivary gland secretions contained an
enzyme that caused fibrin depolymerisation via the hy-
drolysis of ε-(γ-Glu)-Lys isopeptide bonds between poly-
peptide chains in stabilised fibrin. Later, the enzyme that
possessed thrombolytic activity was isolated and identified.
This enzyme was referred to as destabilase [10].
To demonstrate the isopeptidase activity of destabilase,
a synthetic analogue of the dipeptide L-γ-glutamine-p-
nitroanilide (L-γ-Glu-pNA) [11] and D-dimer (the final
proteolytic degradation product of stabilised fibrin) [12]
were used. ε-(γ-Glu)-Lys bonds cross-link D-monomers
in the D-dimer. Destabilase has been shown to exhibit
isopeptidase activity in relation to D-dimers without de-
grading the fibrinogen and serum albumin [13]. This mech-
anism was revealed through an analysis of the N-terminal
amino acid sequence of the γ-chain in the D-monomer
after isopeptidolysis of ε-(γ-Glu)-Lys bonds [14].
The thrombolytic activity of destabilase has also been
demonstrated in an animal (rat) model with a pre-formed
thrombus. The thrombus weight was been found to de-
crease by 85 and 98 % at 48 and 137 h, respectively, after
the intravenous injection of destabilase [15].
In 2000, a comparison of the amino acid sequence of
destabilase with the sequences of other known proteins re-
vealed the similarity of its fragment to Asteria rubens lyso-
zyme, suggesting that destabilase possesses muramidase
activity [16]. Muramidase activity involves the hydrolysis of
the β-(1,4)-glycoside bond between N-acetylmuramic acid
and N-acetylglucosamine in the bacterial peptidoglycan
[17]. The muramidase activity of destabilase was dem-
onstrated by the cell wall disruption of Мicrococcus
lysodeikticus [16]. At the same time, this enzyme with
heat-inactivated muramidase activity still exhibited high
antimicrobial activity against not only bacteria but also
yeasts, fungi, and archaea [13, 18, 19]. It has also been
shown that synthetic amphipathic fragments of the desta-
bilase possess antimicrobial activity [18]. Thus, destabilase
was the first multifunctional i-type invertebrate lysozyme
to be discovered [16], later called Destabilase-Lyzosyme
(mlDL) [20]. At the moment, there is only a three-
dimensional model of mlDL-Ds2 based on the crystal
structure of a highly homologous lysozyme from Tapes
japonica (TJL) [21]. Among the proteins for which the
spatial structure was identified, the primary structure of
TJL is mostly similar to the primary structure of destabi-
lase (identity ~46 %). Based upon indirect observations, it
wassuggested that two distinct active centres in the mol-
ecule of TJL are responsible for its isopeptidase and lyso-
zyme activities [22]. 3D model of mlDL-Ds2 structure
showed that both functional centers are located relatively
close to each other with their overlapping [20].
Because of its properties, mlDL could serve as a potential
thrombolytic agent with a low rate of thrombolysis [13].
Previous studies have described the enzymatic proper-
ties of mlDL purified from leech salivary gland secre-
tions [10, 16, 23, 24]. The isolation and purification of
mlDL directly from the salivary gland secretions of me-
dicinal leeches is a laborious process with a low yield of
the final product. Moreover, mlDL is isolated from the
salivary gland secretions in the form of a destabilase
complex that includes hirudin, 6-keto prostaglandin F1α
and plasma kallikrein inhibitor [23]. Alternatively, re-
combinant mlDL is used to study the properties of the
pure protein. To date, three genes (Ds-1, −2, −3) have
been identified that encode three isoforms of the desta-
bilase (Ds-1, −2, −3) [25, 26]. All isoforms were found in
H. medicinalis. Ds-1 and Ds-2 were found by mRNA
analysis, Ds-3 was found by sequencing of CnBr-
fragments of destabilase isolated from leech’s saliva. The
homology between mlDL isoforms varied from approxi-
mately 66 to 87 % (Additional file 1: Figure S1). Previously,
only two recombinant isoforms of mlDL were expressed
in Escherichia coli (mlDL-Ds2, 3) [27]. Moreover, mlDL-
Ds2 was obtained in a Spodoptera frugiperda baculovirus
system [28]. Nevertheless, the low final product yield im-
peded the study of the properties of the pure enzyme. The
goal of our study was to generate active mlDL isoforms
and compare their enzymatic properties. To this end, we
constructed plasmids with sequences that encoded all of
the mlDL isoforms. We developed the methods for the
expression, isolation and purification of the active mlDL
isoforms and detected and compared their lysozyme (mur-
amidase and lytic), isopeptidase and antimicrobial activ-
ities. Additionally, to test whether the mlDL isoforms
possess antibacterial activity independent of their enzym-
atic activities, tryptic peptides were generated.
Methods
Generation of the recombinant mlDL isoforms in E. coli
DNA fragments that encode the mlDL-Ds1, 2, 3 [25]
were de novo synthesised from oligonucleotides. These
fragments were optimised for expression in E. coli. A list
of the oligonucleotides and a scheme for synthesising
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the fragments are presented in Additional file 2: Table S1
and Additional file 3, respectively. The commercially avail-
able plasmid pET-15b (Novagen, USA) was modified by
adding new multiple cloning sites. The resulting plasmid
was termed pET15MCS (Additional file 3: Figure S2). The
DNA fragments encoding the mlDL isoforms and plasmid
pET15MCS were treated with the restriction endonucle-
ases BamHI and SalI. The restriction products were
ligated. Prepared plasmids were subsequently used for the
standard transformation procedure of E. coli Top10 cells.
PCR selection of the colonies was performed using the
oligonucleotides T7 and T7t. Next, the plasmids were
extracted and sequenced. Because of the identity of the
plasmids that encoded the three mlDL isoforms, we
termed them pET15/Dest. A map of the pET15/Dest plas-
mid is shown in Additional file 3: Figure S3. The E. coli
strain BL21(DE3)-gold was transformed by the plasmids
that encoded the three mlDL isoforms. The transformed
cells were plated on a selective solid medium containing
ampicillin (150 ng/ml) and then incubated at 37 °C for
16 h. Individual colonies of E. coli were inoculated into
super broth (SB) medium containing potassium nitrate
(2 g/l) and cultured at 37 °C overnight. The cultures were
then added to the fresh SB medium containing potassium
nitrate at a 1:20 dilution, and the cells were grown until
optical density OD600 = 0.8. Next, lactose was added to a
final concentration of 10 mM, and the cultures were incu-
bated again at 37 °C for 6 h. Inclusion bodies were then
isolated and solubilised in denaturing buffer containing
8 M urea. The mlDL-Ds1, 2, 3 were isolated using metal
chelate affinity chromatography under denaturing condi-
tions (for details, see Additional file 4).
The purified mlDL isoforms were diluted in 8 M urea
at a final protein concentration below 1 mg/ml and rena-
tured using stepwise dialysis against the solution contain-
ing 20 mM NaH2PO4, 150 mM NaCl with the following
decreasing urea concentration: 4, 2, 1, and 0 M. Each step
lasted at least 8 h. The precipitate was separated by centri-
fugation at 10,000 × g for 20 min.
MALDI-TOF analysis
The protein bands after 1D PAGE were subjected to
trypsin ingel hydrolysis. Gel pieces (2 mm3) were excised
and washed twice with 100 ml of 0.1 M NH4HCO3 and
40 % acetonitrile for 30 min at 37 °C, dehydrated with
100 ml of acetonitrile and air-dried. Then, they were
treated with 4 ml of a 12.5 mg/ml solution of modified
trypsin (Promega) in 40 mM NH4HCO3 and 10%aceto-
nitrile for 16 h at 37 °C. The peptides were extracted
with 8 ml of an aqueous solution of 0.5 % trifluoroacetic
acid for 20 min. Aliquots (2 ml) of the sample were mixed
on a steel target with 0.3 ml of a 2,5-dihydroxybenzoic
acid (Brucker Daltonics, Germany) solution (75 mg/ml in
30 % acetonitrile/0.5 % trifluoroacetic acid). Mass spectra
were recorded on an Ultraflex II MALDI-ToFToF mass
spectrometer (Brucker Daltonics, Germany) equipped with
an Nd laser. The [MH+] molecular ions were measured in
reflector mode; the accuracy of the mass peak measure-
ment was 0.005 %. The fragment ion spectra were gener-
ated by laser-induced dissociation slightly accelerated by
low-energy collision-induced dissociation using helium as
the collision gas. The accuracy of the fragment ion mass
peak measurement was 5 Da. The MS/MS fragments were
identified using the Biotools software (Brucker Daltonics,
Germany) and Mascot MS/MS ion search. Protein identifi-
cation was performed using a peptide fingerprint search
with the Mascot software (MatrixScience Inc., USA). One
missed cleavage, Met oxidation and Cys-ropionamide were
permitted. Protein scores greater then 49 were supposed to
be significant (p < 0.05).
Buffer solutions for activity assays (standard buffers)
We assessed the pH effect on the enzymatic activities
using the following standard buffers [29]: citric acid/so-
dium citrate buffer for the pH range of 1.0–5.0, sodium
citrate/sodium phosphate buffer for the pH range of
5.0–7.0, sodium phosphate/sodium hydroxide buffer for
the pH range of 7.0–12.0, and potassium chloride/so-
dium hydroxide buffer for the pH range of 12.0–13.0.
The total concentration of the components in each buf-
fer was kept at 10 mM. After determining the optimal
pH conditions that corresponded to the activity peaks,
we assessed the ionic strength effect on the enzymatic
activities at the predetermined optimal pH conditions.
In this case, the ionic strength of the solutions varied
with the concentration of NaCl.
Muramidase activity assay
Muramidase activity was determined via clarifying the sus-
pension of lyophilised M. lysodeikticus cells (0.5 mg/ml;
Sigma, USA) after treatment with the mlDL isoforms
[30, 31]. Hen egg white lysozyme (HEWL; Sigma,
USA) was used as a reference lysozyme with known mura-
midase activity under the definite experimental condi-
tions: at 25 °C in 20 mM Na-phosphate buffer, pH 7.4.
The concentrations of both mlDL isoforms and HEWL
varied from 0 to 20 μg/ml, and the sample volume was
200 μl. Incubation took place in the wells of a 96-well
plate at 25 °C for 30 min. The optical densities were mea-
sured using a photometer (Multiskan Ascent, Thermo-
Fisher Scientific, USA) at the wavelength of 405 nm. The
muramidase activities of the mlDLisoforms were calcu-
lated using the following formula:
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where ΔOD405
d and ΔOD405
h are the differences in optical
densities were measured before and after treatment with
the mlDL isoforms at different pH values and HEWL at
pH 7.4, respectively, and Ah is the known muramidase
activity of HEWL at pH 7.4, which was provided by the
producer (in units). Negative values that were calculated
using formula (1) were set to zero.
Lytic activity assay
Lytic activity was estimated by measuring the amount of
total protein that was released from the E. coli (strain
Top10) and B. subtilis (strain 186RT) cells following
treatment with the mlDL isoforms. The overnight cul-
tures of E. coli and B. subtilis were reseeded in fresh LB
medium at a dilution of 1:20 and subsequently grown
until OD600 = 1. Two hundred microlitres of the cell cul-
ture was precipitated by centrifugation at 10,000 × g for
2 min. Next, the pellet was resuspended in an equal vol-
ume of standard buffer followed by the addition of
mlDL isoforms at concentrations of 20 μg/ml. The mix-
ture was incubated at 37 °C for 30 min. Next, the sample
was diluted with distilled water to a final volume of 1 ml
and then centrifuged at 10,000 × g for 10 min. The super-
natant was collected, and the amount of total protein re-
leased from the cells was measured using the Bradford
method (QuickStart™ Bradford Protein Assay, Bio-Rad,
USA) according to the manufacturer’s recommendations.
It is well known that many gram-negative bacteria are
lysed only in the presence of ethylenediaminetetraacetic
acid (EDTA), which contributes to outer membrane dis-
ruption. Therefore, we have also determined lytic activity
in the presence of EDTA (5 mM) in E. coli.
Isopeptidase activity assay
Isopeptidase activity was determined by cleavage of the
chromogenic substrate L-γ-Glu-pNA (Sigma, USA) fol-
lowing treatment with the mlDL isoforms [32]. The mlDL
isoforms at concentrations of 300 μg/ml were added to
standard buffers containing L-γ-Glu-pNA at a concentra-
tion of 1 mg/ml. The solutions (each sample was 200 μl)
were incubated in a 96-well plate at 37 °C for 48 h. The
standard buffers containing L-γ-Glu-pNA without mlDL
isoforms treatment were used as control samples to ex-
clude pH and ionic strength effects on substrate integrity.
The optical densities were measured using a photometer
(Multiskan Ascent) at a wavelength of 405 nm. The
isopeptidase activity was calculated using the following
formula:
A activity unitsð Þ ¼ ΔOD405d–ΔOD405c




c are the differences in the
optical densities, which were measured before and after
treatment with mlDL isoforms for the experimental and
control samples, respectively, at the same pH values.
Negative values that were calculated using formula (2)
were set to zero.
Preparation of tryptic peptides from the mlDL isoforms
Trypsin (0.1 μg/ml; Gibco®, USA) was added to the solu-
tions containing mlDL isoforms at the concentration of
200 μg/ml. The solutions were incubated at 37 °C for
1 h. Next, trypsin was inhibited by adding phenylmethane-
sulfonylfluoride (PMSF; Sigma, USA) at a concentration
of 1 mM, and the solutions were subsequently incubated
at room temperature for additional 3 h. We used a refold-
ing buffer (20 mM NaH2PO4, 150 mM NaCl) that had
undergone the same preparation procedures as a control
solution.
Antibacterial activity assay
The antibacterial activity of the mlDL isoforms and their
tryptic peptides was independently determined using the
following two methods:
Method 1. Determination of the growth curves of bac-
teria treated with the mlDL isoforms and their tryptic
peptides. The overnight cultures of E. coli and B. subtilis
cells were inoculated into LB medium at a dilution of
1:20 and then the mlDL isoforms or their tryptic pep-
tides were added at final concentrations varying from 0
to 20 μg/ml along with the twofold dilutions. The cells
were subsequently grown in a 96-well plate at 37 °C for
7 h. The sample volume was 200 μl. The optical density
(OD600) was measured every 30 min for each sample at
a wavelength of 600 nm using a photometer. The total
observation time was 7 h for each sample. Next, the
growth curves were expressed as the time dependence of
OD600.
Method 2. Determination of the minimum inhibitory
concentrations (MICs) of the mlDLisoforms and their
tryptic peptides [33]. A total of 150 μl of LB medium
containing 5*105 CFU/ml E. coli or B. subtilis was inocu-
lated into each well of a 96-well plate. The cells were in-
cubated with mlDL isoforms at 37 °C for 16–18 h, and
their tryptic peptides at the concentrations were varied
from 0 to 20 μg/ml. Next, the samples were plated onto
solid LB medium in Petri dishes. The Petri dishes were
incubated at 37 °C for 18 h. The growth colonies were
counted, and the MICs were determined.
Fibrinolytic activity assay
Fibrinolytic activity was assayed using the fibrin plate
method [34] with a slight modification. Briefly, fibrin
plates were prepared by the addition of 6 mg of fibrino-
gen (Tehnologia-Standart, Russia) and 0.5 U of thrombin
(Tehnologia-Standart, Russia) to 15 ml of 0.1 M Na-
phosphate buffer (pH 7.4) containing 0.15 M NaCl. The
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resulting solution was immediately inoculated onto a
90-mm Petri dish. Fibrin gel formation continued at
room temperature for 4 h. Droplets (5 μl) of the solutions
containing mlDL isoforms at the concentration of 1 mg/ml
were carefully placed on the plate and incubated at room
temperature for 48 h. We measured the diameters of the
lysed zones produced by each droplet. The measurements
of each lysed zone were performed in three directions
followed by the calculation of the mean value. The experi-
ments were repeated independently in three fibrin plates.
Percentage of stabilized fibrin in fibrin clot was determined
according to the amount of soluble protein in 2 % acetic
acid [35]. Unstabilized fibrin is dissolved in acid, stabilized
fibrin is precipitated.
Circular dichroism
The CD spectra were recorded using a Chiroscan CD
spectrophotometer (Applied Photophysics, UK). The spec-
tra weremeasured between 180 and 280 nm (1 nm step) at
20 °C. A 2 mm-pathlength cell with a detachable window
was used. The protein concentrations were 2 mg/ml in
the buffer (5 mM Na2HPO4, pH 2.2, 3.2 and 6.5).
Results
Generation of the active recombinant mlDL isoforms in
E. coli
To optimise the accumulation of the mlDL isoforms in E.
coli cells, we empirically selected the strains (8 strains),
media (7 media) and cultivation schemes. All optimisation
procedures and an optimal refolding scheme and cultiva-
tion method are described in Additional file 4. The final
yields of the active mlDL isoforms were 25–30 mg per 1
litre of the bacterial culture. An electrophoregram of the
isolated mlDL-Ds3 is shown in Fig. 1. Well-separated
bands with molecular weights of approximately 16, 28 and
44 kDa were detected. Using MALDI-TOF analysis we
confirmed that these bands consisted of mlDL (Additional
file 5. Figure S4). Thus, we supposed that the recombinant
mlDL-Ds3 forms stable oligomeric complexes. Similar
results were obtained for other mlDL isoforms, mlDL-Ds1
and mlDL-Ds2 (data not shown). But by gel-filtration
chromatography on Sephadex 200 mlDL isoforms form
only one peak corresponding to a monomer of mlDL
(Additional file 6: Figure S5).
Muramidase activity of the mlDL isoforms
We determined the pH effect on the muramidase activity
of the mlDL isoforms by clarifying the suspension of
lyophilised M. lysodeikticus. All measurements were con-
ducted in the linear range of the decrease of absorbance
M. lysodeikticus suspension before reaching the saturation
level. It is shown in Additional file 7 at pH 6.3 without
NaCl. Figure 2a shows the results of the assay for mlDL-
Ds3. mlDL-Ds3 exhibited muramidase activity at a wide
pH range of 5.0–12.0, with a peak at pH 6.3. We also de-
tected an extremely high activity peak at pH 2.2. Sub-
sequently, we analysed the effect of ionic strength on
muramidase activity under these optimal pH conditions.
mlDL-Ds3 exhibited the greatest activity at pH 2.2 with
the NaCl concentration adjusted to 150 mM (Fig. 2b) and
at pH 6.3 without NaCl addition (Fig. 2c). Similar results
were obtained for other mlDL isoforms, mlDL-Ds1and
mlDL-Ds2 (Additional file 8: Figure S7). The muramidase
actibity of mlDL isoforms at the pH 6.3 without NaCl per-
formed in the Table 1.
Lytic activity of the mlDL isoforms
We determined the pH effect on the lytic activity of the
mlDL isoforms by measuring the amount of total protein
that was released from the gram-positive B. subtilis and
gram-negative E. coli cells. mlDL-Ds3 exhibited lytic
activity against B. subtilis at the pH range of 5.0 to 9.0
(Fig. 3a). In this pH range, mlDL-Ds3 possessed almost
equal activity values. Therefore, to determine the effect of
ionic strength on lytic activity, we selected pH 6.3, which
Fig. 1 SDS-PAGE of mlDL-Ds3. mlDL-Ds3 was isolated using metal
chelate affinity chromatography. mlDL-Ds3 was heating 10 min at
95 °C with 2 % 2-mercaptoethanol. M—molecular weight marker
(kDa). Electrophoresis was performed in 13.5 % acrylamide/bis gel.
The gel was stained with Coomassie 250G
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corresponded to the conditions in the muramidase activity
assay. mlDL-Ds3 exhibited the greatest activity at NaCl
concentrations ranging from 0 to 200 mM (Fig. 3b). Simi-
lar results were obtained for other mlDL isoforms, mlDL-
Ds1 and mlDL-Ds2 (Additional file 9: Figure S8).
We determined the lytic activity of the mlDL isoforms
against E. coli cells. In this case, we also tested the effect
of EDTA on the lytic activity of the mlDL isoforms. It is
well known that EDTA contributes to outer membrane
disruption, providing access to peptidoglycan in gram-
negative bacteria [36]. Peptidoglycan is known to serve
as a substrate for lysozymes. The mlDL isoforms exhib-
ited the greatest lytic activity without EDTA at the pH
range of 5.0–9.0 (data not shown). In the presence of
EDTA (5 mM), the greatest lytic activity slightly
shifted toward alkaline conditions with the pH range
of 6.0–10.0. Therefore, as for B. subtilis, we selected
pH 6.3 to determine the effect of ionic strength on
lytic activity. The mlDL isoforms exhibited the great-
est lytic activity at 0 M NaCl without EDTA and at
0.3 M NaCl with EDTA (Additional file 9: Figure S8).
The lytic actibity of mlDL isoforms at the pH 6.3 without
NaCl and EDTA performed in the Table 1.
Isopeptidase activities of the mlDL isoforms
We determined the pH effect on the isopeptidase activity
of the mlDL isoforms based on the production of p-
nitroanilide L-γ-Glu-pNA, which is measured by the
absorbance at 405 nm. Figure 4a shows the results of the
assay for mlDL-Ds3. mlDL-Ds3 exhibited isopeptidase ac-
tivity in the pH range of 4.5–7.0, with peak activity at
pH 5.5. Subsequently, we analysed the effect ionic strength
a
b c
Fig. 2 Muramidase activity of mlDL-Ds3. Effects of pH (a) and ionic strength (b, c) on the muramidase activity of mlDL-Ds3. The activity (in units)
was calculated relative to the reference enzyme HEWL according to formula (1). (n = 5)
Table 1 Comparison of the mlDL fermentative activities and half-maximal diapasones
Muramidase activity
(in lysozyme units)
Lytic activity Isopeptidase activity Half-maximal pH and I values for
in activity units Km, μM kkat, ×10−2 s−1 muramidase activity lytic activity isopeptidase activity
mlDL-Ds1 5200 ± 450 0. 079 ± 0.005 850 ± 70 40 7 pH 2.5–3, I = 0–0.25 M; pH 4.5–10 pH 4.5–7.5
mlDL-Ds2 2450 ± 250 0. 035 ± 0.003 660 ± 60 50 8 pH 4.5–12, I = 0–0.05 M I = 0–0.4 M I = 0–0.1 M
mlDL-Ds3 10,000 ± 600 0. 136 ± 0.005 1780 ± 160 20 5
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on isopeptidase activity at pH 5.5. mlDL-Ds3 exhibited
the greatest activity without the addition of NaCl (Fig. 4b).
Similar results were obtained for the other destabilase
isoforms, mlDL-Ds1and mlDL-Ds2 (Additional file 10:
Figure S9). The isopeptidase actibity of mlDL isoforms at
the pH 5.5 without NaCl performed in the Table 1.
Antimicrobial activity of the mlDL isoforms
We determined the antimicrobial activity of the mlDL iso-
forms and their tryptic peptides (mlDL-Ds1t, mlDL-Ds2t,
mlDL-Ds3t) using two methods. The tryptic peptides were
generated to test whether the mlDL isoforms exhibit anti-
bacterial activity independent of their enzymatic activities.
To eliminate the influence of an intact protein, we mea-
sured the muramidase activity of tryptic peptides. This
mixture did not provide the enzymatic activity.
According to Method 1, we determined the growth
curves of bacteria that were exposed to the enzymes and
their tryptic peptides at different concentrations. The
growth of both gram-positive and gram-negative bacteria
was inhibited by mlDL isoforms and their tryptic
peptides. Notably, the tryptic peptides of all mlDL iso-
forms exhibited more efficient bacterial growth inhibition
than the whole enzymes did. Figure 5 shows the growth
curves for mlDL-Ds3 and mlDL-Ds3t. Similar results were
obtained for the other mlDL isoforms: mlDL-Ds1 and
mlDL-Ds2 (data not shown).
In Method 2, we determined the MICs of the mlDL iso-
forms and their tryptic peptides (Table 2). Fewer MICs
were determined for the whole mlDL isoforms and their
tryptic peptides in B. subtilis than for E. coli. Moreover,
for both bacterial species, the tryptic peptides had fewer
MICs than the corresponding whole enzymes. These data
confirm the results obtained with Method 1.
Fibrinolytic activity of the mlDL isoforms
Fibrinolytic activity was determined by measuring the
diameters of the lysed zones that resulted from the place-
ment of droplets of the enzyme-containing solutions on
fibrin plates. In this case, we investigated not only intact
mlDL isoforms but also heat-inactivated (at 95 °C for 2 h)
enzymes and their tryptic peptides to test whether the
a b
Fig. 3 Lytic activity of mlDL-Ds3. Effects of pH (a) and ionic strength (b) on the lytic activity of mlDL-Ds3. The activity was expressed as the
concentration of protein released from the cells of B. subtilis. (n = 5)
a b
Fig. 4 Isopeptidase activity of mlDL-Ds3. The effect of pH (a) and ionic strength (b) on the isopeptidase activity of mlDL-Ds3. The effect of ionic
strength on the isopeptidase activity was determined at pH 5.5. Isopeptidase activity was calculated according to formula (2). (n = 5)
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fibrinolytic activity was enzymatic. We determined that
only the intact mlDL isoforms exhibited fibrinolytic activ-
ity. All of the intact mlDL isoforms caused lysed zones
with equal diameters (6 ± 1 mm). A representative image
of one such plate is shown in Fig. 6a.
Also, we performed the SDS-PAGE analysis of lysed
zones (line 1, Fig. 6b). This fibrin gel was stabilized on
70 %. Solid zone of gel (untreated zone) was dissolved in
2 % acetic acid. Soluble fraction (line 2) and precipitate
(dissolved in 5 % SDS, line 3) were analyzed by SDS-
PAGE, too. We found the γ-γ fibrin chain only in unso-
luble fraction of fibrin. This chain is absent in soluble
control fraction and fraction from lysed zone by mlDL-
Ds3. Then we analyzed the stabilized fibrin treated by
mlDL-Ds3 (Fig. 6c). We incubated stabilized fibrin clot
with mlDL-Ds3 at 37 °C for 96 h. As the control we used
the buffer without mlDL. We found the γ-γ fibrin chain
only in unsoluble fraction of control sample of stabilized
fibrin (lane 4).
Discussion
In this study, we obtained all known isoforms of mlDL
(mlDL-Ds1, mlDL-Ds2, mlDL-Ds3) from medicinal leeches
in the form of recombinant proteins in E. coli. We opti-
mised the expression, isolation and purification procedures
and obtained a fivefold increase in the yield of the recom-
binant mlDL isoforms compared with previous studies.
This allowed us to investigate the enzymatic and antibac-
terial activities of these isoforms.
MALDI-TOF analysis data suggested that the recom-
binant mlDL isoforms form stable oligomeric complexes
(Additional file 5: Figure S4). We have identified pure
mlDL and the dimer and trimer complexes. According
to gel-filtration chromatography (Additional file 6: Fig-
ure S5), mlDL forms have only one peak, corresponding
to a mlDL’s-monomer. This fact does not explain the
origin of these oligomeric structures. We suppose that
the total protein from purified mlDL consists mostly of
monomeric form, and other oligomers represent only a
small part of the total protein. However observations
about oligomeric forms are in agreement with previous
investigations that showed that some i-lysozymes could
form active dimer and trimer complexes. However, the
oligomeric complexes of the destabilase isoforms were
not disrupted in the solution with high ionic strength, in
contrast to other i-type lysozymes [17].
Furthermore, we investigated lysozyme (muramidase
and lytic), isopeptidase and antimicrobial activities of the
recombinant mlDL isoforms. The greatest muramidase
activity of the mlDL isoforms was detected within the
pH range of 5.0–12.0. Surprisingly, we also detected the
peak of the muramidase activity at extremely acidic
pH 2.2. Most of the known i-type lysozymes exhibit the
greatest muramidase activity within the pH range of
6.0–8.0 [17], but these lysozymes have not yet been
shown to possess activity at the extremely acidic pH. We
have analysed the circular dichroism (CD) spectra of
mlDL isoforms at different pH conditions: 2.2 and 6.5
are corresronds the maximum of muramidase activity,
a b
Fig. 5 Inhibition of bacterial growth. The growth curves of the E. coli strain Top10 (a) and B. subtilis (b). cont—control cells incubated without
mlDL-Ds3; mlDL-Ds3 and mlDL-Ds3t—the cells incubated in the presence of mlDL-Ds3 and mlDL-Ds3t, respectively, at a concentration of 5 μg/ml.
Each growth curve was obtained by averaging three independent measurements
Table 2 Minimum inhibitory concentrations (MICs) of the recombinant mlDL isoforms and their tryptic peptides
mlDL-Ds1 mlDL-Ds2 mlDL-Ds3 mlDL-Ds1t mlDL-Ds2t mlDL-Ds3t
MIC (μg/ml), E.coli 2.5 1.3
MIC (μg/ml), B.subtilis 1.3 0.6
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3.2—minimum of muramidase activity (Additional file 11:
Figure S10). All probes of the mlDL exhibited similar CD
spectra. However, the spectra are shifted to the long wave-
length waves with increasing pH to all isoforms of mlDL.
Consequently, we suppose that the conformation of the
protein does not significantly affect the change in activity.
The ionic strength effect on muramidase activity dif-
fered for the different optimal pH values. The increase
in NaCl concentration at pH 6.3 strongly inhibited the
muramidase activity of the mlDL isoforms, a result that
is in a good agreement with those obtained for mlDL
isolated from the salivary gland secretion.
To test the lytic activity, we used gram-positive bacteria
B. subtilis and gram-negative bacteria E. coli. The bacterial
cell wall contains peptidoglycan, a main substrate for lyso-
zyme. Peptidoglycan of gram-positive bacteria is located
outside of the cell, whereas peptidoglycan of gram-negative
bacteria is hidden by the outer membrane. EDTA disrupts
the outer membrane in gram-negative bacteria, facilitating
the enzyme’s access to peptidoglycan [36]. The mlDL iso-
forms exhibited the greatest lytic activity within the pH
range of 5.0–9.0 for both B. subtilis and E. coli. These data
are in agreement those of the previous study. In the pres-
ence of EDTA, the optimal pH range shifted toward an al-
kaline pH. In contrast to the muramidase activity, we have
not detected the lytic activity at the acidic pH values.
The isopeptidase activity of the mlDL isoforms was
determined by the production of p-nitroanilide from L-
γ-Glu-pNA, which was detected by the absorbance at
405 nm. This chromogenic substrate is mainly used to
study gamma-glutamyl transpeptidase and possesses a
low specificity for isopeptidase. Therefore, the optimal
conditions for cleavage of this substrate have been shown
to require high enzyme concentrations (300–500 μg/ml)
and a long incubation time (above 48 h). The mlDL iso-
forms exhibited isopeptidase activity in a rather narrow
range of pH values (from 5.0 to 6.5). This is in agreement
with the previous observations for other i-type lysozymes
that possessed isopeptidase activity. We revealed that iso-
peptidase activity was very sensitive to the ionic strength.
It has not been detected at NaCl concentrations above
0.3 M. For isopeptidase activity we measured Km and
kkat. It was found that for all isoforms Km = 20–50 μM
and kkat = 5–8 × 10
−2 s−1. So high Km and low kkat can be
explained also by low specificity of substrate. Although
these values are comparable to those obtained previously
for mlDL-Ds2 (Km = 50 μM, kkat =0.1 × 10
−2 s−1) [13] and
TJL (Km = 20 μM, kkat = 0.2 × 10
−4 s−1) [32].
For all fermentative activities we found the half-
maximal pH and I values (Table 1). These values were
similar for all mlDL isoforms: for lytic activity—pH 4.5–10
and I = 0–0.4 M, for isopeptidase activity—pH 4.5–7.5 and
I = 0–0.1 M. For muramidase activity mlDL had two
ranges: pH 2.5–3 and I = 0–0.25 M, pH 4.5–12 and I = 0–
0.05 M. This information allows us to suggest the similar-
ity of their enzymatic properties. Previous studies have
demonstrated the antimicrobial activity of heat-inactivated
mlDL [19]. This antimicrobial effect was also observed
with synthetic amphipathic fragments of mlDL [18]. We
used the mlDL isoforms and their tryptic peptides to in-
vestigate antimicrobial activity. We revealed the inhibition
of bacterial growth (E. coli and B. subtilis) in the presence
of the mlDL isoforms and their tryptic peptides. The
tryptic peptides exhibited more efficient inhibition of bac-
terial growth than the entire enzymes. This was confirmed
by MIC determination. The MICs of tryptic peptides were
lower than those of the entire mlDL isoforms. The anti-
microbial activity detected in the tryptic peptides of the
mlDL isoforms confirmed that this activity is non-
enzymatic. The antimicrobial activity that was independent
of muramidase activity has been shown for other inverte-
brate lysozymes, but the mechanism of this action remains
unclear.
For the first time, we have revealed that recombinant
mlDL isoforms exhibit fibrinolytic activity. We determined
that only the intact mlDL isoforms possess fibrinolytic ac-
tivity. Neither tryptic peptides nor heat-inactivated protein
exhibited fibrinolytic activity, suggesting that this activity
is enzymatic and requires structural organisation of the
active centre.
Fig. 6 Fibrinolytic activity of mlDL-Ds3. a Lysed zone formation in
the fibrin plate after treatment with the intact entire mlDL-Ds3.
1—mlDL-Ds3, 2—mlDL-Ds3t, 3—heat-inactivated mlDL-Ds3. b
SDS-PAGE of fibrin gel lysed by mlDL: 1–probe from mlDL lysed
zone, 2–soluble fraction of stabilized fibrin by 2 % acetic acid treatment,
3–unsoluble fraction of stabilized fibrin by 2 % acetic acid treatment, (c)
SDS-PAGE of stabilized fibrin after mlDL-Ds3 treatment at 37 °C for 96 h:
4—unsoluble fraction of stabilized fibrin after incubation with control
buffer, 5—unsoluble fraction of stabilized fibrin after incubation with
mlDL-Ds3, 6—soluble fraction of stabilized fibrin after incubation with
control buffer, 7—soluble fraction of stabilized fibrin after incubation
with mlDL-Ds3, 8—mlDL-Ds3. M—molecular weight marker (kDa).
Electrophoresis was performed in 12 % acrylamide/bis gel. The gel
was stained with Coomassie 250G. α, β, γ—α, β, γ-chains of human
fibrinogen (63.5, 56, 47 kDa respectively)
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Conclusions
We isolated all of the currently known mlDL isoforms
from medicinal leeches and demonstrated the enzymatic
activities of all of the recombinant isoforms. All of the
mlDL isoforms exhibited almost identical patterns of pH
and ionic strength effects on the activities. We also
found that the antimicrobial activity of the mlDL isoforms
is muramidase activity-independent and non-enzymatic.
We found that the tryptic peptides of the mlDL isoforms
exhibited more efficient inhibition of bacterial growth and
had lower MICs than the whole enzymes did. We also
showed that only the whole mlDL isoforms possess fi-
brinolytic activity.
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